2026
article
OpenAlex
Mehrdad Hashemi, Pezhman Shafiei Asheghabadi, Mahdi Moassesfar, Saba Mashhadikhan et autres
ir, it, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Lei Wang, Pezhman Shafiei Asheghabadi, Saba Mashhadikhan, Sevda Nasirzade et autres
Cancer remains a major global health challenge, with therapeutic resistance significantly limiting treatment success. Traditional approaches, including surgery, chemotherapy, and radiotherapy, often encounter barriers such as metastasis and adverse effects on healthy tissues. The Warburg effect, which describes cancer cells’ reliance on …
cn, ir, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Mehrdad Hashemi, Niloufar Salimian, Nafiseh Sharifi, Pezhman Shafiei Asheghabadi et autres
Hematological malignancies, including leukemia, lymphoma, and multiple myeloma (MM), are cancers originating in the hematopoietic system, characterized by diverse pathogenesis and clinical features. Non-coding RNAs (ncRNAs) such as microRNAs (miRNAs) and long non-coding RNAs, play critical roles in regulating gene expression and …
ir, us
(code pays fourni par la source)
2025
article
OpenAlex
Mehrdad Hashemi, Pezhman Shafiei Asheghabadi, Mahdi Moassesfar, Reza Mohammadi et autres
ir, us
(code pays fourni par la source)
2025
book-chapter
OpenAlex
Mehrdad Hashemi, Safa Tahmasebi, Pezhman Shafiei Asheghabadi, Amirhossein Mardi et autres
ir, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mehrdad Hashemi, Asal Abolghasemi Fard, Bita Pakshad, Pezhman Shafiei Asheghabadi et autres
Lung cancer (LC) is one of the most common causes of cancer-related death worldwide. It has been demonstrated that the prognosis of current drug treatments is affected by a variety of factors, including late stage, tumor recurrence, inaccessibility to appropriate treatments, and, …
ir, ca
(code pays fourni par la source)
2024
book-chapter
OpenAlex
Mehrdad Hashemi, Vahid Tavakolipour, Reza Morovatshoar, Ali Samadpour et autres
ir
(code pays fourni par la source)